These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 12497830)

  • 1. [Vasopeptidase inhibitors: new pharmacologic classes, new therapeutic opportunities].
    Morganti A
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):829-31. PubMed ID: 12497830
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopeptidase inhibition as a new concept in antihypertensive therapy.
    Dendorfer A; Dominiak P
    Kidney Blood Press Res; 2000; 23(3-5):178-9. PubMed ID: 11031714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasopeptidase inhibition: a new mechanism of action--a new antihypertensive drug].
    Waeber B
    Praxis (Bern 1994); 2000 Apr; 89(16):649-53. PubMed ID: 10823018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natriuretic peptide neurohormonal system modulation by vasopeptidase inhibitors--the novel therapeutical approach of hypertension treatment.
    Machowska A; Juszczak K; Novak P; Thor P
    Folia Med Cracov; 2009; 50(3-4):35-42. PubMed ID: 21853869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of natriuretic peptides in blood pressure regulation].
    Hirata Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():56-9. PubMed ID: 15506337
    [No Abstract]   [Full Text] [Related]  

  • 6. Omapatrilat.
    Armstrong PW; Lorell BH; Nissen S; Borer J
    Circulation; 2002 Aug; 106(6):e9011-2. PubMed ID: 12187916
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasopeptidase inhibition: a new direction in cardiovascular treatment.
    Asher JR; Naftilan AJ
    Curr Hypertens Rep; 2000 Aug; 2(4):384-91. PubMed ID: 10981174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasopeptidase inhibitors. Omapatrilat in hypertension and heart failure].
    Heinzl S
    Med Monatsschr Pharm; 2000 Feb; 23(2):38-41. PubMed ID: 10701306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential hypertension and natriuretic peptides].
    Kanmatsuse K; Fujita H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():110-2. PubMed ID: 15506350
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasopeptidase inhibition: a new concept in blood pressure management.
    Burnett JC
    J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopeptidase inhibitors--concepts and evidence.
    Ruschitzka F; Corti R; Quaschning T; Hermann M; Lüscher TF
    Nephrol Dial Transplant; 2001 Aug; 16(8):1532-5. PubMed ID: 11477147
    [No Abstract]   [Full Text] [Related]  

  • 12. [Omapatrilat for treatment of heart failure].
    Yamazaki T
    Nihon Rinsho; 2007 May; 65 Suppl 5():173-5. PubMed ID: 17571381
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasopeptidase inhibitors in heart failure.
    Dawson A; Struthers AD
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):156-9. PubMed ID: 12563565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new class of potent antihypertensive agents. Especially systolic pressure is significantly reduced].
    MMW Fortschr Med; 1999 Nov; 141(47):8. PubMed ID: 10912157
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasopeptidase inhibition. A new mechanism of action for the treatment of hypertension and cardiac insufficiency].
    Kolloch R; Offers E
    Internist (Berl); 2001 Feb; 42(2):290-6. PubMed ID: 11244883
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasopeptidase inhibitors and their potential role in diabetes.
    Chowdhury TA; Khan T
    Diabetes Obes Metab; 2002 Mar; 4(2):89-95. PubMed ID: 11940105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasopeptidase inhibition. Intense and long-lasting blood pressure lowering].
    Arnheim K
    Internist (Berl); 2000 Jan; 41(1):A33-4. PubMed ID: 10712084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Omapatrilat--new drug for patients with hypertension and heart failure].
    Dzielska-Olczak M
    Pol Merkur Lekarski; 2005 Oct; 19(112):556-8. PubMed ID: 16379325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.
    Lapointe N; Parker TG; Tsoporis JN; Nguyen QT; Marcotte F; Adam A; Lou I; Rouleau JL
    Can J Cardiol; 2005 Mar; 21(3):291-7. PubMed ID: 15776120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omapatrilat.
    Drugs R D; 1999 Apr; 1(4):350-1. PubMed ID: 10566062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.